CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $907,000 | -76.8% | 108,061 | -85.5% | 0.26% | -84.0% |
| Q1 2020 | $3,916,000 | +141.3% | 747,300 | +151.4% | 1.63% | +193.4% |
| Q4 2019 | $1,623,000 | +12.1% | 297,300 | 0.0% | 0.56% | +2.2% |
| Q3 2019 | $1,448,000 | -29.7% | 297,300 | 0.0% | 0.54% | -29.6% |
| Q2 2019 | $2,060,000 | -2.8% | 297,300 | -2.5% | 0.77% | -15.4% |
| Q1 2019 | $2,120,000 | +134.3% | 305,000 | +96.8% | 0.92% | +103.3% |
| Q4 2018 | $905,000 | -24.3% | 155,000 | -61.2% | 0.45% | -52.5% |
| Q2 2016 | $1,196,000 | +1413.9% | 400,000 | +700.0% | 0.95% | +1115.4% |
| Q3 2015 | $79,000 | -30.1% | 50,000 | +36.6% | 0.08% | -18.8% |
| Q2 2015 | $113,000 | – | 36,590 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |